FDA Orange Book · active-ingredient family
Doxapram hydrochloride
Doxapram hydrochloride is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DOPRAM · NDA 014879
1
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DOPRAMRLD | HIKMA | NDA 014879 | AP | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DOXAPRAM HYDROCHLORIDE | CHARTWELL INJECTABLE | ANDA 076266 | AP | Jan 10, 2003 | |
| DOXAPRAM HYDROCHLORIDE | WATSON LABS | ANDA 073529 | — | Jan 30, 1992 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Doxapram hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

